Design Therapeutics (DSGN) Change in Accured Expenses: 2020-2021
Historic Change in Accured Expenses for Design Therapeutics (DSGN) over the last 2 years, with Dec 2021 value amounting to -$26,000.
- Design Therapeutics' Change in Accured Expenses fell 103.60% to -$26,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $2.4 million, marking a year-over-year increase of 69.09%. This contributed to the annual value of -$1.2 million for FY2024, which is 2.17% up from last year.
- Per Design Therapeutics' latest filing, its Change in Accured Expenses stood at -$26,000 for Q4 2021, which was down 101.89% from $1.4 million recorded in Q3 2021.
- In the past 5 years, Design Therapeutics' Change in Accured Expenses registered a high of $2.5 million during Q3 2020, and its lowest value of -$1.8 million during Q1 2020.
- Over the past 2 years, Design Therapeutics' median Change in Accured Expenses value was $361,500 (recorded in 2020), while the average stood at $481,000.
- Data for Design Therapeutics' Change in Accured Expenses shows a peak YoY increase of 174.86% (in 2021) and a maximum YoY decrease of 30,700.00% (in 2021) over the last 5 years.
- Design Therapeutics' Change in Accured Expenses (Quarterly) stood at $722,000 in 2020, then plummeted by 103.60% to -$26,000 in 2021.
- Its Change in Accured Expenses stands at -$26,000 for Q4 2021, versus $1.4 million for Q3 2021 and -$306,000 for Q2 2021.